Effects of trophoblast cell-surface antigens 2 gene downregulated by RNA interference on invasion of human prostate carcinoma cells and urokinase-type plasminogen activator protein
Feilun Cui
Abstract
Feilun Cui
Abstract
Objective To explore the effects and mechanism of trophoblast cell-surface antigens 2 (TROP-2) on invasion of human prostate cancer cells.Methods After human prostate cancer PC-3 cell line was transfected with TROP-2 small interfering RNA (siRNA),the mRNA and protein levels of TROP-2 were determined by using real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) and Western blotting respectively.The invasion ability was evaluated by Transwell.The urokinase-type plasminogen activator (uPA) protein of cancer cells was examined by Western blotting.Results The mRNA and protein expression levels of TROP-2 were greatly inhibited in PC-3 cancer cells transfected with TROP-2 siRNA.The results of the Transwell assay showed that the number of cells penetrating the membrane in Con-A,Con-B,and siRNA groups (5,10 and 20 nmoL/L) was 128.16 ± 3.89,127.58 ± 3.56,102.56 ± 3.28,76.38 ± 3.25,and 39.89 ±3.18,respectively (P <0.05).The results from Western blotting assay showed that the uPA protein in siRNA groups was reduced significantly.Conclusion TROP-2 siRNA inhibit the invasion of prostate cancer cells through down-regulation of uPA. Key words: Prostate carcinoma; Trophoblast cell-surface antigens 2 gene; Invasion; Urokinase-type plasminogen activator
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the effects and mechanism of trophoblast cell-surface antigens 2 (TROP-2) on invasion of human prostate cancer cells.Methods After human prostate cancer PC-3 cell line was transfected with TROP-2 small interfering RNA (siRNA),the mRNA and protein levels of TROP-2 were determined by using real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) and Western blotting respectively.The invasion ability was evaluated by Transwell.The urokinase-type plasminogen activator (uPA) protein of cancer cells was examined by Western blotting.Results The mRNA and protein expression levels of TROP-2 were greatly inhibited in PC-3 cancer cells transfected with TROP-2 siRNA.The results of the Transwell assay showed that the number of cells penetrating the membrane in Con-A,Con-B,and siRNA groups (5,10 and 20 nmoL/L) was 128.16 ± 3.89,127.58 ± 3.56,102.56 ± 3.28,76.38 ± 3.25,and 39.89 ±3.18,respectively (P <0.05).The results from Western blotting assay showed that the uPA protein in siRNA groups was reduced significantly.Conclusion TROP-2 siRNA inhibit the invasion of prostate cancer cells through down-regulation of uPA. Key words: Prostate carcinoma; Trophoblast cell-surface antigens 2 gene; Invasion; Urokinase-type plasminogen activator
Key concepts: Transfection, Plasminogen activator, Molecular biology, Blot, Trophoblast, Small interfering RNA, Gentamicin protection assay, Urokinase